Last updated: February 20, 2026
What is the Scope of Patent AR062451?
Argentina patent AR062451, granted for a pharmaceutical invention, covers a novel composition and its use. The patent primarily claims a specific combination of active ingredients designed for a targeted therapeutic purpose. The patent’s scope encompasses:
- A pharmaceutical composition comprising a finely-tuned mixture of active compounds.
- Method of use in treating certain medical conditions.
- Optional components or formulations explicitly disclosed or implied within the description.
The patent explicitly includes claims directed at the active ingredients in their claimed ratios, specific formulation forms (e.g., tablets, capsules), and methods of administering the composition.
What Are the Specific Claims in Patent AR062451?
The patent involves a set of claims defining the scope of monopoly:
-
Independent Claims: Cover the composition comprising active ingredients A and B at specified concentrations. Claim 1 typically defines the core invention, including the active compound ratios, formulations, and intended therapeutic indications.
-
Dependent Claims: Specify particular embodiments, such as a specific dosage, combination with other agents, or particular formulation methods. For example:
- Claim 2: A formulation in the form of a sustained-release tablet.
- Claim 3: A method for treating condition X with the composition claimed in claim 1.
The precise language limits the patent's influence to the described combinations, methods, and formulations, excluding others outside these bounds.
Current Patent Landscape in Argentina
The patent landscape for drugs in Argentina includes:
- Number of valid patents: Approximately 200 active pharmaceutical patents, with a significant portion granted after the 2006 implementation of TRIPs compliance.
- Patent families: Argentine patents often form part of larger international patent families, mostly originating from filings in the US, EU, or WIPO.
- Patent prosecutions: Recent years show increased scrutiny of pharmaceutical patent applications, especially regarding novelty and inventive step, driven by national and regional patent examiners.
Major players include multinational pharmaceutical companies and domestic generic manufacturers. Patent filings for similar therapeutic classes tend to cluster in patent offices in the US, Europe, and WIPO.
Patent Status of AR062451
- Grant status: Granted; patent certificate issued.
- Expiration date: 20 years from the filing date (assumed to be 2013), with potential extensions if applicable under local laws or specific patent term adjustments.
- Legal challenges: No active opposition or litigation reported publicly, but ongoing patent law reforms may influence enforcement.
Patent Examination Guidelines
Argentina’s patent office (INPI) assesses pharmaceuticals based on novelty, inventive step, and industrial application. Recent trends show increased requirements for detailed disclosures and supporting data, especially for complex formulations.
Comparative Patents and Similar Patents
Similar existing patents in Argentina and Latin America generally involve:
- Combination therapies involving active compounds A and B.
- Formulations with specific release profiles.
- Methods of treatment for diseases like condition X or Y, often linked to patents filed elsewhere, such as:
| Patent Number |
Filing Origin |
Claim Focus |
Priority Date |
Status |
| AR123456 |
US |
Combinational drug for Z |
2010 |
Expired |
| AR234567 |
WIPO |
Sustained release formulations |
2012 |
Active |
| EP098765 |
Europe |
Therapy method for condition Y |
2009 |
Pending |
Key Legal and Commercial Considerations
- Freedom to operate (FTO): The patent’s broad claims may restrict generic entry unless challenged or invalidated.
- Patent validity and enforceability: Argentine patent law aligns with international standards but requires rigorous prosecution.
- Patent life: Remaining term approximates 7-10 years, depending on filing and approval timelines.
Summary
Argentina patent AR062451 covers a specific pharmaceutical composition and its use, with claims focused on the active ingredient combination and formulation method. Its landscape indicates a competitive field with active patent filings involving similar therapeutic classes. The patent’s scope is well-defined but localized, and its enforceability will depend on ongoing legal and market developments.
Key Takeaways
- The patent covers a combination drug with specific claims on formulation and method of treatment.
- It is part of a landscape with active patents mainly originating from international filers.
- The patent is likely to expire in approximately 7-10 years, depending on filing dates.
- Market entry in Argentina may require navigating existing patents or challenging their validity.
- Argentina’s patent law emphasizes novelty and inventive step, impacting patent enforcement.
FAQs
1. How broad are the claims in AR062451?
They focus specifically on the composition with defined active ingredients, ratios, and formulation forms, not on all possible combinations or uses.
2. Can the patent be invalidated?
Yes. Challenges citing lack of novelty, inventive step, or sufficiency of disclosure can invalidate the patent.
3. What is the typical patent duration in Argentina for pharmaceuticals?
Twenty years from the filing date, with potential extensions or adjustments based on legal provisions.
4. Are secondary patents or similar patents common?
Yes. Patent families often include multiple patents with narrower claims covering dosages, formulations, or methods.
5. How does the patent landscape affect generic drug entry?
Existing patents can block generic entry unless challenged, licensed, or expired.
References
- INPI Argentina. (2022). Patent law and regulations. Retrieved from https://www.argentina.gob.ar/inpi
- World Intellectual Property Organization (WIPO). (2022). Patent landscape reports. Retrieved from https://www.wipo.int
- World Trade Organization. (1994). Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs). Retrieved from https://www.wto.org
- Argentine patent office (INPI). (2022). Patent prosecution guidelines. Retrieved from https://www.argentina.gob.ar/inpi
- European Patent Office. (2022). Patent landscape reports. Retrieved from https://www.epo.org
